BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1879183)

  • 1. Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
    Kahan FM; Rogers JD
    Chemotherapy; 1991; 37 Suppl 2():21-5. PubMed ID: 1879183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical phase I study on intramuscular imipenem/cilastatin sodium].
    Onishi A; Otawa M; Hara K
    Jpn J Antibiot; 1991 Aug; 44(8):860-76. PubMed ID: 1920812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twice daily intramuscular imipenem/cilastatin in the treatment of skin and soft tissue infections.
    Sexton DJ; Wlodaver CG; Tobey LE; Yangco BG; Graziani AL; MacGregor RR
    Chemotherapy; 1991; 37 Suppl 2():26-30. PubMed ID: 1879184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.
    Pietroski NA; Graziani AL; Lawson LA; Bland JA; Rogers JD; MacGregor RR
    Antimicrob Agents Chemother; 1991 May; 35(5):972-5. PubMed ID: 1854179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular imipenem/cilastatin in multiple-dose treatment regimens: review of the worldwide clinical experience.
    Garau J; Calandra GB
    Chemotherapy; 1991; 37 Suppl 2():44-52. PubMed ID: 1879187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.
    Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):85-8. PubMed ID: 1864280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular imipenem/cilastatin treatment of upper reproductive tract infection in women: efficacy and use characteristics.
    McGregor JA; Christensen FB; French JI
    Chemotherapy; 1991; 37 Suppl 2():31-6. PubMed ID: 1879185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall clinical utility of the intramuscular preparation of imipenem/cilastatin.
    MacGregor RR
    Chemotherapy; 1991; 37 Suppl 2():53-7. PubMed ID: 1879188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
    Chan CY; Lai KN; Lam AW; Li PK; Chung WW; French GL
    J Antimicrob Chemother; 1991 Feb; 27(2):225-32. PubMed ID: 2055813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
    Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H; Shiratori K; Ueda S; Takagi N; Umemura S; Shionoiri H
    Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration.
    Signs SA; Tan JS; Salstrom SJ; File TM
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1400-3. PubMed ID: 1510434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and clinical efficacy of imipenem/cilastatin sodium in neonates].
    Azagami S; Kusumoto Y; Oikawa T; Osano M; Shiro H; Shirai Y; Nakamura M
    Jpn J Antibiot; 1988 Nov; 41(11):1704-14. PubMed ID: 3210302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in neonates].
    Sato H; Narita A; Matsumoto K; Suzuki H; Nakazawa S; Nakanishi Y; Nakazawa S; Chikaoka H; Koido R; Kamigaki M
    Jpn J Antibiot; 1988 Nov; 41(11):1657-70. PubMed ID: 3210300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous imipenem/cilastatin during intermittent haemofiltration.
    Alarabi AA; Cars O; Danielson BG; Salmonson T; Wikström B
    J Antimicrob Chemother; 1990 Jul; 26(1):91-8. PubMed ID: 2211452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections].
    Konaga E; Takeuchi H; Orita K; Fuchimoto S; Ogawa K; Kitagawa T; Tokuda N; Kimura H; Hamada F; Nishiyama Y
    Jpn J Antibiot; 1991 Dec; 44(12):1341-50. PubMed ID: 1798068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in neonates and premature infants].
    Toyonaga Y; Sugita M; Hori M; Joh K
    Jpn J Antibiot; 1988 Nov; 41(11):1671-91. PubMed ID: 3210301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group].
    Fujii R; Sakata H; Inyaku F; Fujita K; Maruyama S; Yoshioka H; Hashira S; Tajima T; Nakazawa S; Sato H
    Jpn J Antibiot; 1989 Apr; 42(4):953-72. PubMed ID: 2671429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Matsuda S; Oh K; Tateno M; Kojima Y; Hirabayashi K; Okada E; Doko F; Kawai J
    Jpn J Antibiot; 1991 Dec; 44(12):1359-67. PubMed ID: 1798070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group].
    Matsuda S; Suzuki M; Oh K; Ishikawa M; Soma A; Takada H; Shimizu T; Makinoda S; Fujimoto S; Chimura T
    Jpn J Antibiot; 1988 Nov; 41(11):1731-41. PubMed ID: 3062205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and tolerance of intravenously administered imipenem/cilastatin in the treatment of septicaemia.
    Linton DM; Aitchison JM; Potgieter PD
    S Afr Med J; 1989 Jun; 75(11):529-31. PubMed ID: 2658141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.